More Women Than Men Reported Injuries After COVID Vaccine, CDC's V-safe Data Show; Data collected from the U.S. Centers for Disease Control and Prevention’s V-safe app reveal that women
by Paul Alexander
and also recipients of the Moderna and Johnson & Johnson COVID-19 vaccines were disproportionately affected by adverse events following their vaccination.
‘COVID vaccine affected more women than men
The V-safe data also reveal that of the approximately 3.35 million V-safe users who reported one or more adverse events, a significantly higher number of women reported such events.
1.9 million white women compared to approximately 700,000 white men.
Nearly 136,000 Asian women compared to approximately 81,000 Asian men.
More than 161,000 Black or African American women compared to nearly 47,000 Black or African American men.
According to ICAN:
“There was also a disproportionate number of negative events reported by women versus men.
“This is consistent with what was seen in Pfizer’s initial post-authorization safety report sent to the U.S. Food and Drug Administration (a report had to be obtained by lawsuit) which similarly showed a disproportionate number of neurological events experienced by women following the Pfizer Covid-19 vaccine.”
Brian Hooker, chief scientific officer for Children’s Health Defense, told the Defender we may eventually see a shift in some of these discrepancies: “I think, over time, we might see a shift … especially in younger individuals.”’
“The Moderna vaccine, interestingly, even though less shots of it were administered, appears within this data set to have a higher rate of adverse effects.”
Dr. Madhava Setty, a board-certified anesthesiologist and senior science editor for The Defender, suggested the disproportionate percentage of adverse events associated with the Moderna vaccine may be related to Moderna’s larger dose, compared with Pfizer.’
Adverse events for Moderna, J&J recipients disproportionately high
According to data presented by Statista, of the more than 610 million COVID-19 vaccines administered in the U.S. as of Sept. 7, 59.2% (361.3 million) were Pfizer, 37.6% (229.8 million) were Moderna and 3.1% (18.9 million) were J&J.
However, the V-safe data reveal that out of the 3.35 million people who reported being affected in some way by the vaccines, 48.3% received the Moderna vaccine and 4.7% received the J&J vaccine.
Both percentages are higher than that of the general population that received those vaccines.
According to ICAN, “These data also reflect a disproportionate amount of negative health impacts, including medical events, following the Moderna vaccine versus the Pfizer vaccine.”